Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions.
about
Toxoplasma gondii infection and behaviour - location, location, location?Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in JapanChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyDepression during pegylated interferon-alpha plus ribavirin therapy: prevalence and predictionAssociation of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon TreatmentCytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction.Psychiatric clearance for patients started on interferon-alpha-based therapies.Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatmentAnxiety in cancer patients.Neuropsychiatric adverse effects of interferon-alpha: recognition and management.Mood disorders associated with interferon treatment: theoretical and practical considerations.Anterior cingulate activation and error processing during interferon-alpha treatmentInflammatory cytokine-associated depressionSide effects of therapy of hepatitis C and their management.The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.Major depression during interferon-alpha treatment: vulnerability and prevention.Symptom control.A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').Psychiatric Adverse Effects Of Interferon Therapy.Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging targetCandidate mechanisms for chemotherapy-induced cognitive changes.Depression following pegylated interferon-alpha: characteristics and vulnerability.Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.Neuropathic Ocular Pain due to Dry Eye is Associated with Multiple Comorbid Chronic Pain Syndromes.Adjuvant treatment of melanomaA comparison of modified directly observed therapy to standard care for chronic hepatitis C.SASLT practice guidelines: management of hepatitis C virus infection.Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancerSASLT guidelines: Update in treatment of Hepatitis C virus infection.Role of inflammatory cytokines in depression: Focus on interleukin-1β.Risk factors for the development of depression in patients with hepatitis C taking interferon-α.Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.Interferon, tryptophan and depression.Negative regulation of human astrocytes by interferon (IFN) α in relation to growth inhibition and impaired glucose utilization.An Exploration of Depressive Symptoms in Hepatitis C Patients Taking Interferon-alpha: Increase in Sickness Behaviors but not Negative Cognitions.A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.Methylphenidate for alpha-interferon induced depression.Cognitive Impairment Associated with Cancer: A Brief Review.Homicidal ideation secondary to interferon.
P2860
Q22306158-2CB5CF4A-D288-469D-8F51-95AFEC327B1BQ24658320-80910BF4-EFA9-4F5A-8E46-B6DB25C5779AQ27011451-B53B90A3-899A-4F16-B0E5-9313982C8FD7Q27477533-0BDDB2A2-628F-4783-B774-5B58755F8B2EQ28387292-795EC30B-0E8E-4760-B1C4-8D96121F253EQ30390049-87C11026-C4A7-4456-9DD2-C599B62BD049Q33708662-F36F056A-8CAF-4A76-831A-A993C0441322Q33816643-B0943E54-629B-47F8-8089-F7DE1D3A509AQ34067712-9292C19C-2157-4358-B8D8-086757C39D4BQ34081783-94ECE451-8731-47A0-8A05-E6133A5414B9Q34219107-81D8F88C-6017-483F-931D-FAC3D2021EBEQ34350258-AF5AA076-D781-43D7-A5D1-57C122D77D0DQ34825010-81A7F9C5-EF4D-43BA-9E13-FF5FFD4159F3Q34984142-1223E9F0-7D90-4FD0-B23B-1F8F493AF61FQ34996746-917367B3-8832-4064-B5D8-D188A0445C79Q35237145-7AE29084-2A76-455A-8094-D51A0452F61AQ35553856-9E136F9A-2637-4FD3-BB25-50285BEB3C38Q35645887-5E2EA983-5AEE-4055-A1BA-C9C630B5F41FQ35713956-8765090C-646F-4E11-AD2A-94A6753D2405Q35776955-C7A1215B-0397-407E-B106-763D58D28F8AQ35898051-2AF0352C-3C08-4CDB-A334-4FCD4BCC974DQ36183715-331DDAAC-1760-4252-9737-D44024CFCFE1Q36206254-81EB1880-1917-46E0-A00B-B8078CF424F2Q36642407-2B337CAE-439C-4E9C-BC77-37F29CF3B05CQ36656595-CAC9D8B7-8A53-42F7-884D-A073C166CD95Q36997166-2BAAA92B-2D90-4177-AF63-B5FEB16A7CB0Q37019765-DB7E4404-4F21-4498-84E7-E9753C9CEA6BQ37124637-63643AA0-D2E1-4598-ABC8-FE7F170D867CQ37191347-EB56D9BA-0F45-4573-B939-2E2112CC656EQ37216507-B2A24AB0-CFCD-471E-B201-2E94A1E463F0Q37593869-E4C8B4C9-DD17-4F05-A0F1-1438B9053764Q37886673-86072A0A-C64A-4D9D-B445-54A85A36CD8BQ37976412-ED3ED4CD-0781-480E-9386-DD5FAC48FBEFQ38777707-5F8029B3-7A42-4771-9971-5B86C92580B0Q39342614-5AFE22BA-23A7-40B4-89B6-00E3D6DD4A42Q41991403-E96E868C-762A-44E3-BEFC-1FCFF9C713D5Q44194141-DAC111D7-F160-4755-B738-80515FDB4A7FQ46675054-0BA43202-E903-47CE-B3E6-3C3DFC2D011EQ50533188-5221032A-21D3-4419-B3EF-CC398DD6C355Q50585574-9D538844-80D8-451C-9FC2-48D2132B72C5
P2860
Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Psychiatric side effects of in ...... anisms, and future directions.
@ast
Psychiatric side effects of in ...... anisms, and future directions.
@en
type
label
Psychiatric side effects of in ...... anisms, and future directions.
@ast
Psychiatric side effects of in ...... anisms, and future directions.
@en
prefLabel
Psychiatric side effects of in ...... anisms, and future directions.
@ast
Psychiatric side effects of in ...... anisms, and future directions.
@en
P2093
P1476
Psychiatric side effects of in ...... anisms, and future directions.
@en
P2093
P304
P356
10.1200/JCO.2000.18.11.2316
P407
P577
2000-06-01T00:00:00Z